Free Trial

BioMarin Pharmaceutical (BMRN) SEC Filings & 10K Form

BioMarin Pharmaceutical logo
$57.55 -0.46 (-0.79%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$57.47 -0.08 (-0.14%)
As of 05/23/2025 06:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent BioMarin Pharmaceutical SEC Filings

DateFilerForm TypeView
05/20/2025
4:58 PM
BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
8:58 AM
BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/19/2025
4:22 PM
BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-C
05/16/2025
8:44 PM
BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-C
05/16/2025
4:16 PM
BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-C
05/16/2025
6:54 AM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2025
6:59 AM
BioMarin Pharmaceutical (Subject)
Form SC TO-C
05/13/2025
10:32 AM
BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
Form SCHEDULE 13G/A
05/02/2025
11:33 AM
BioMarin Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2025
9:05 AM
BioMarin Pharmaceutical (Subject)
Hubbard Cristin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/29/2025
8:14 AM
BioMarin Pharmaceutical (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G/A
04/08/2025
3:09 PM
BioMarin Pharmaceutical (Filer)
Form DEF 14A
04/08/2025
3:12 PM
BioMarin Pharmaceutical (Filer)
Form DEFA14A
03/20/2025
6:38 PM
BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
8:36 AM
BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
6:51 PM
BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
6:53 PM
BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:23 PM
BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:25 PM
BioMarin Pharmaceutical (Issuer)
Hubbard Cristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:17 PM
BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:19 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:22 PM
BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:11 PM
BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:15 PM
BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:17 PM
BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:19 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:18 PM
BioMarin Pharmaceutical (Issuer)
Walbert Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
7:21 PM
BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
12:54 PM
BioMarin Pharmaceutical (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2025
9:26 AM
BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
3:07 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
1:14 PM
BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
Form SCHEDULE 13G/A
12/03/2024
5:15 PM
BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
1:44 PM
BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
1:27 PM
BioMarin Pharmaceutical (Subject)
Guyer Charles Greg (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
2:01 PM
BioMarin Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/01/2024
3:50 PM
BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2024
3:51 PM
BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:29 PM
BioMarin Pharmaceutical (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G
09/24/2024
7:31 AM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
4:54 PM
BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the May 1st funding window clos
09/04/2024
11:52 AM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
4:02 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
4:00 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
10:48 AM
BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
12:14 PM
BioMarin Pharmaceutical (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
07/01/2024
3:19 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:28 PM
BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:29 PM
BioMarin Pharmaceutical (Issuer)
HERON ELAINE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
9:18 AM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2024
5:28 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
9:49 AM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2024
5:18 PM
BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
1:22 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2024
9:10 AM
BioMarin Pharmaceutical (Subject)
LAWLIS V BRYAN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2024
9:18 AM
BioMarin Pharmaceutical (Subject)
Mueller Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
9:28 AM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/28/2024
9:36 AM
BioMarin Pharmaceutical (Subject)
Davis George Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BMRN) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners